?牛病毒性腹泻BVDV病毒E2F, E2R抗体Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Initial binding to target cell probably involves interaction of E(rns) with glycosaminoglycans. E1 and/or E2 are responsible of cell attachment with CD46 and subsequent fusion after 牛病毒性腹泻BVDV病毒E2F, E2R抗体internalization of the virion by endocytosis (Probable).
P7 forms a leader sequence to properly orient NS2 in the membrane.
Uncleaved NS2-3 is required for production of infectious virus.
NS2 protease seems to play a vital role in viral RNA replication control and in the 牛病毒性腹泻BVDV病毒E2F, E2R抗体pathogenicity of the virus.
NS3 displays three enzymatic activities: serine protease, NTPase and RNA helicase.
NS4A is a cofactor for the NS3 protease activity.
RNA-directed RNA polymerase NS5 replicates the viral (+) and (-) genome.
Also known as:
polyprotein [Bovine viral diarrhea virus 1]; POLG_BVDVN; Envelope glycoprotein E2; BVDV Envelope glycoprotein E2; PestiV1gp1 polyprotein [ Bovine viral diarrhea virus 1 ].牛病毒性腹泻BVDV病毒E2F, E2R抗体
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: BVDV.
●
Immunogen: Recombinded BVDV Envelope glycoprotein E2.
●
牛病毒性腹泻BVDV病毒E2F, E2R抗体Predicted Molecular Weight: 45kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl051Cp01胰岛素样生长因子2(IGF2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2)
kl051Eq01胰岛素样生长因子2(IGF2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2)
kl051Ga01胰岛素样生长因子2(IGF2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2)
kl051Gu01胰岛素样生长因子2(IGF2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2)
kl051Hu01胰岛素样生长因子2(IGF2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2)
kl051Mu01胰岛素样生长因子2(IGF2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2)
kl051Po01胰岛素样生长因子2(IGF2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2)
kl051Ra01胰岛素样生长因子2(IGF2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2)
kl051Rb51胰岛素样生长因子2(IGF2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 2 (IGF2)
kl052Bo01胰岛素样生长因子结合蛋白1(IGFBP1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 1 (IGFBP1)
kl052Cp01胰岛素样生长因子结合蛋白1(IGFBP1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 1 (IGFBP1)
kl052Fi01胰岛素样生长因子结合蛋白1(IGFBP1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 1 (IGFBP1)
kl052Ga01胰岛素样生长因子结合蛋白1(IGFBP1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 1 (IGFBP1)
kl052Hu01胰岛素样生长因子结合蛋白1(IGFBP1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 1 (IGFBP1)
kl052Mu01胰岛素样生长因子结合蛋白1(IGFBP1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 1 (IGFBP1)
kl052Po01胰岛素样生长因子结合蛋白1(IGFBP1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 1 (IGFBP1)
kl052Ra01胰岛素样生长因子结合蛋白1(IGFBP1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 1 (IGFBP1)
kl053Bo01胰岛素样生长因子结合蛋白2(IGFBP2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2)
kl053Hu01胰岛素样生长因子结合蛋白2(IGFBP2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2)
kl053Mu01胰岛素样生长因子结合蛋白2(IGFBP2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2)
kl053Po01胰岛素样生长因子结合蛋白2(IGFBP2)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 2 (IGFBP2)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话